￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is lenvatinib/lenvatinib (Lenvima) a targeted drug or an immune drug?

2026-02-01 22:25:32

Check Details
Who should not use fezolinetant?

2026-02-01 22:25:32

Check Details
Is Belumosudil a domestic drug or an imported drug?

2026-02-01 22:25:32

Check Details
Common possible side effects of Brivaracetam

2026-02-01 22:25:32

Check Details
Comparative analysis of the efficacy and side effects of DaliRasen and LeboRasen

2026-02-01 22:25:32

Check Details
Olaparib’s out-of-pocket purchase price and medical insurance coverage in 2025

2026-02-01 22:25:32

Check Details
Detailed instructions and medication instructions for Venetoclax/Venetoclax (Vekela)

2026-02-01 22:25:32

Check Details
Differences and clinical advantages between asinib/asiminib and orebatinib

2026-02-01 22:25:32

Check Details
Analysis of the latest market price and reference cost per box of Ritlecitinib

2026-02-01 22:25:32

Check Details
Sparsentan’s launch time and approval information in China

2026-02-01 22:25:32

Check Details
The main differences between ixazomib (Enleri) and bortezomib and analysis of applicable populations

2026-02-01 22:25:32

Check Details
What is rubitin/rubicatin (Zanbiga) and its clinical application analysis

2026-02-01 22:25:32

Check Details
Category
相关知识